Bispecific Her2 × cotinine antibody in combination with cotinine-(histidine)2-iodine for the pre-targeting of Her2-positive breast cancer xenografts.
about
In vitro and in vivo application of anti-cotinine antibody and cotinine-conjugated compounds.Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.The making of bispecific antibodiesOrientation and density control of bispecific anti-HER2 antibody on functionalized carbon nanotubes for amplifying effective binding reactivity to cancer cells.An anti-EGFR × cotinine bispecific antibody complexed with cotinine-conjugated duocarmycin inhibits growth of EGFR-positive cancer cells with KRAS mutations.Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma
P2860
Bispecific Her2 × cotinine antibody in combination with cotinine-(histidine)2-iodine for the pre-targeting of Her2-positive breast cancer xenografts.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Bispecific Her2 × cotinine antibody in combination with cotinine-
@nl
Bispecific Her2 × cotinine ant ...... tive breast cancer xenografts.
@en
type
label
Bispecific Her2 × cotinine antibody in combination with cotinine-
@nl
Bispecific Her2 × cotinine ant ...... tive breast cancer xenografts.
@en
prefLabel
Bispecific Her2 × cotinine antibody in combination with cotinine-
@nl
Bispecific Her2 × cotinine ant ...... tive breast cancer xenografts.
@en
P2093
P2860
P1476
Bispecific Her2 × cotinine ant ...... tive breast cancer xenografts.
@en
P2093
Hwa Kyoung Lee
In-Hoo Kim
Junho Chung
Se Hun Kang
Seok-Ki Kim
Soomin Yoon
Yun-Hee Kim
P2860
P2888
P304
P356
10.1007/S00432-013-1548-4
P577
2013-12-01T00:00:00Z